Non-alcoholic Steatohepatitis with Fibrosis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis with Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Non-alcoholic Steatohepatitis Registry Platform Study
AstraZeneca’s registry platform trial for non-alcoholic steatohepatitis with fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects [EARLY_Phase 1]
Hepion Pharmaceuticals reports completion of a single-dose ADME study of [14C]-Rencofilstat in healthy male subjects, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 [Phase 2]
Phase 2 study evaluating the safety and efficacy of rencofilstat in adults with non-alcoholic steatohepatitis with fibrosis (NASH F3) has co…